I am not happy, especially not for the patients!
First, blaming the FDA for sure. Must think about DDS(Labopharm) a long time ago. They had 2
good trials fase 3 but not good enough for the FDA, so they had to do another trial. DDS was
finished. And big pharma was satisfied!
So is ABBV satisfied now with their "humira" etc
Second, i wrote times ago that the bulk af my GLPG shares were sold. I bought the first 2000 at an
average of 13 EUR, so was one of my better investments!
Third, i still have TH shares in my second account, so i will give P L the chance to execute. I wiil wait it
out because "oncology" is where i put my money in. But there are other players further in the process!!
And with much better following from investor community.
But that can be a + for TH if (IF) they can execute.............
Fourth, GLPG has allready the partner TH is searching for ......GILD!!!
And 5 BILLION in cash!!!
Good luck sir
bfw - (7/16/2021 10:13:37 AM) RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financial and others Hmm...so GLPG's inferior stock performance can be blamed on the FDA ;)
Oh well, as long as you are happy being down about 70% in a year or back to 5 year lows.
For reference, TH was $2.55 5 years ago.
I'm not happy with that performance either but at least it is up on a 5 year basis.
Perhaps time to give Paul a chance to execute.
bfw